DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Sokal EM, Hoppenbrouwers K, Vandermeulen C et al.
Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.
J Infect Dis 2007;
196: 1749-1753
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.